EX-99.1 2 snbr-ex991_6.htm EX-99.1 snbr-ex991_6.htm

Exhibit 99.1

FOR IMMEDIATE RELEASE

 

Sleep Number Announces RECORD Fourth-Quarter AND Full-YEAR 2018 Results

  

Fourth-quarter net sales grew 13% to $412 million, with full-year net sales up 6% to a record $1.53 billion

Fourth-quarter EPS grew 108% to $0.81, with full-year EPS up 24% to $1.92

Revolving credit facility increased from $300 million to $450 million

Provides 2019 earnings outlook of $2.25 to $2.75 per diluted share, an increase of 17% to 43% versus 2018

  

MINNEAPOLIS – (February 13, 2019) – Sleep Number Corporation (NASDAQ: SNBR) today reported record results for the year ended December 29, 2018.

  

Fourth-quarter Statement of Operations Review

Net sales increased 13% (up 11% adjusted); net sales for the second half of 2018 increased 8% (up 12% adjusted); see Reconciliation of Non-GAAP Financial Measures tables on page 10

Operating income increased to $38 million, or 9.3% of net sales, a 380 basis-point rate improvement versus the prior year’s fourth quarter

 

Earnings per diluted share increased 108% to $0.81 (up 76% adjusted); earnings per diluted share for the second half of 2018 increased 31% (up 48% adjusted); see Reconciliation of Non-GAAP Financial Measures tables on page 10

  

“Our purpose-driven brand and our revolutionary new 360® smart beds are driving enthusiastic consumer engagement and accelerated performance, including 12% adjusted net sales growth and 48% adjusted EPS growth for the second half of 2018,” stated Shelly Ibach, President and CEO. “We expect this trajectory to continue in 2019 as we advance our initiatives to drive demand, leverage our business model and deploy capital efficiently.”

  

Full-year Statement of Operations Review

Net sales increased 6% to $1.53 billion in 2018, including a 3% comparable sales gain and 3 percentage points of growth from new stores

 

Operating income increased to $92 million, or 6.0% of net sales, while absorbing approximately $16 million of 360 smart bed transition impacts

 

Earnings per diluted share increased 24% to $1.92, compared with $1.55 for 2017

 

  

Cash Flows and Balance Sheet Review

Generated $132 million of operating cash flows in 2018

 

Invested $46 million in capital expenditures, with $481 million of capital invested in the business over the past six years, in addition to building essential infrastructure and growth driving capabilities

 

Increased share repurchases 86% to $279 million in 2018, bringing total cash returned to shareholders to $738 million over the past six years

 

As of December 29, 2018, the remaining authorization under our Board-approved share repurchase program was $186 million which is sufficient to support 2019 planned repurchases of $125 to $145 million

 

Return on invested capital (ROIC) was 16.0% for the year, which compares favorably to our high single-digit weighted average cost of capital

On February 11, 2019, we amended our revolving credit facility to increase our aggregate availability from $300 million to $450 million. The credit agreement matures in February 2024

  

Financial Outlook

The company expects to generate full-year 2019 earnings per diluted share of between $2.25 and $2.75, a 17% to 43% increase versus full-year 2018 earnings per diluted share of $1.92. The outlook assumes 6% to 10% net sales growth for 2019. The 2019 outlook assumes an estimated effective income tax rate of 24.5%, compared to 19.6% for 2018. The company anticipates 2019 capital expenditures to be $50 to $60 million.

 


Sleep Number Announces Fourth-quarter and Full-year 2018 Results – Page 2 of 10

 

Conference Call Information

Management will host its regularly scheduled conference call to discuss the company’s results at 5 p.m. EST (4 p.m. CST; 2 p.m. PST) today. To listen to the call, please dial 800-593-9959 (international participants dial 517-308-9340) and reference the passcode “Sleep.” To access the webcast, please visit the investor relations area of the Sleep Number website at http://www.sleepnumber.com/eng/aboutus/InvestorRelations.cfm. The webcast replay will remain available for approximately 60 days.

  

About Sleep Number Corporation

The leader in sleep innovation, Sleep Number delivers proven, quality sleep through effortless, adjustable comfort and biometric sleep tracking. Sleep Number’s revolutionary 360® smart bed and proprietary SleepIQ® technology platforms are proving the connection between sleep and well-being. With one of the most comprehensive databases of biometric consumer sleep data and ranked #1 in J.D. Power’s 2018 Mattress Satisfaction Report*, Sleep Number is improving lives by individualizing sleep experiences. And with a commitment to improving the well-being of over one million youth by 2025, Sleep Number is redefining the future of health and wellness – for everyone. To experience better quality sleep, visit SleepNumber.com or one of our over 580 Sleep Number® stores located in all 50 states. For additional information, visit our newsroom and investor relations site.

  

*Sleep Number received the highest score in the J.D. Power 2015, 2017 and 2018 Mattress Satisfaction Reports of customers’ satisfaction with their mattress. Visit jdpower.com/awards.

  

Forward-looking Statements

Statements used in this news release relating to future plans, events, financial results or performance are forward-looking statements subject to certain risks and uncertainties including, among others, such factors as current and future general and industry economic trends and consumer confidence; the effectiveness of our marketing messages; the efficiency of our advertising and promotional efforts; our ability to execute our company-controlled distribution strategy; our ability to achieve and maintain acceptable levels of product and service quality, and acceptable product return and warranty claims rates; our ability to continue to improve and expand our product line; consumer acceptance of our products, product quality, innovation and brand image; industry competition, the emergence of additional competitive products, and the adequacy of our intellectual property rights to protect our products and brand from competitive or infringing activities; the potential for claims that our products, processes, advertising, or trademarks infringe the intellectual property rights of others; availability of attractive and cost-effective consumer credit options; pending and unforeseen litigation and the potential for adverse publicity associated with litigation; our manufacturing processes with minimal levels of inventory, which may leave us vulnerable to shortages in supply; our dependence on significant suppliers and our ability to maintain relationships with key suppliers, including several sole-source suppliers; the vulnerability of key suppliers to recessionary pressures, labor negotiations, liquidity concerns or other factors; rising commodity costs and other inflationary pressures; risks inherent in global sourcing activities, including tariffs and the potential for shortages in supply; risks of disruption in the operation of either of our two primary manufacturing facilities; increasing government regulations; the adequacy of our and third party information systems to meet the evolving needs of our business and existing and evolving risks and regulatory standards applicable to data privacy and security; the costs, distractions and potential disruptions to our business related to upgrading our management information systems; the vulnerability of our and third-party information systems to attacks by hackers or other cyber threats that could compromise the security of our systems, result in a data breach or disrupt our business; and our ability to attract, retain and motivate qualified management, executive and other key employees, including qualified retail sales professionals and managers.  Additional information concerning these and other risks and uncertainties is contained in the company’s filings with the Securities and Exchange Commission (SEC), including the Annual Report on Form 10-K, and other periodic reports filed with the SEC. The company has no obligation to publicly update or revise any of the forward-looking statements in this news release.

# # #

Investor Contact: Dave Schwantes; (763) 551-7498; investorrelations@sleepnumber.com

Media Contact: Susan Oguche; (763) 551-7059; susan.oguche@sleepnumber.com

 


Sleep Number Announces Fourth-quarter and Full-year 2018 Results – Page 3 of 10

 

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Statements of Operations

(unaudited – in thousands, except per share amounts)

 

 

 

Three Months Ended

 

 

 

December 29, 2018

 

 

% of

Net Sales

 

 

December 30, 2017

 

 

% of

Net Sales

 

Net sales

 

$

411,825

 

 

 

100.0

%

 

$

363,279

 

 

 

100.0

%

Cost of sales

 

 

160,746

 

 

 

39.0

%

 

 

142,475

 

 

 

39.2

%

Gross profit

 

 

251,079

 

 

 

61.0

%

 

 

220,804

 

 

 

60.8

%

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

 

175,899

 

 

 

42.7

%

 

 

161,793

 

 

 

44.5

%

General and administrative

 

 

29,431

 

 

 

7.1

%

 

 

32,036

 

 

 

8.8

%

Research and development

 

 

7,629

 

 

 

1.9

%

 

 

6,856

 

 

 

1.9

%

Total operating expenses

 

 

212,959

 

 

 

51.7

%

 

 

200,685

 

 

 

55.2

%

Operating income

 

 

38,120

 

 

 

9.3

%

 

 

20,119

 

 

 

5.5

%

Other expense, net

 

 

2,093

 

 

 

0.5

%

 

 

209

 

 

 

0.1

%

Income before income taxes

 

 

36,027

 

 

 

8.7

%

 

 

19,910

 

 

 

5.5

%

Income tax expense

 

 

9,037

 

 

 

2.2

%

 

 

4,119

 

 

 

1.1

%

Net income

 

$

26,990

 

 

 

6.6

%

 

$

15,791

 

 

 

4.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share – basic

 

$

0.83

 

 

 

 

 

 

$

0.40

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share – diluted

 

$

0.81

 

 

 

 

 

 

$

0.39

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of weighted-average shares outstanding:

 

Basic weighted-average shares outstanding

 

 

32,411

 

 

 

 

 

 

 

39,627

 

 

 

 

 

Dilutive effect of stock-based awards

 

 

1,018

 

 

 

 

 

 

 

1,037

 

 

 

 

 

Diluted weighted-average shares outstanding

 

 

33,429

 

 

 

 

 

 

 

40,664

 

 

 

 

 

 


 


Sleep Number Announces Fourth-quarter and Full-year 2018 Results – Page 4 of 10

 

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Statements of Operations

(unaudited – in thousands, except per share amounts)

 

 

 

Twelve Months Ended

 

 

 

December 29, 2018

 

 

% of

Net Sales

 

 

December 30, 2017

 

 

% of

Net Sales

 

Net sales

 

$

1,531,575

 

 

 

100.0

%

 

$

1,444,497

 

 

 

100.0

%

Cost of sales

 

 

603,614

 

 

 

39.4

%

 

 

547,150

 

 

 

37.9

%

Gross profit

 

 

927,961

 

 

 

60.6

%

 

 

897,347

 

 

 

62.1

%

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

 

687,380

 

 

 

44.9

%

 

 

650,357

 

 

 

45.0

%

General and administrative

 

 

119,378

 

 

 

7.8

%

 

 

127,269

 

 

 

8.8

%

Research and development

 

 

28,775

 

 

 

1.9

%

 

 

27,806

 

 

 

1.9

%

Total operating expenses

 

 

835,533

 

 

 

54.6

%

 

 

805,432

 

 

 

55.8

%

Operating income

 

 

92,428

 

 

 

6.0

%

 

 

91,915

 

 

 

6.4

%

Other expense, net

 

 

5,907

 

 

 

0.4

%

 

 

877

 

 

 

0.1

%

Income before income taxes

 

 

86,521

 

 

 

5.6

%

 

 

91,038

 

 

 

6.3

%

Income tax expense

 

 

16,982

 

 

 

1.1

%

 

 

25,961

 

 

 

1.8

%

Net income

 

$

69,539

 

 

 

4.5

%

 

$

65,077

 

 

 

4.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share – basic

 

$

1.97

 

 

 

 

 

 

$

1.58

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share – diluted

 

$

1.92

 

 

 

 

 

 

$

1.55

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of weighted-average shares outstanding:

 

Basic weighted-average shares outstanding

 

 

35,256

 

 

 

 

 

 

 

41,212

 

 

 

 

 

Dilutive effect of stock-based awards

 

 

909

 

 

 

 

 

 

 

873

 

 

 

 

 

Diluted weighted-average shares outstanding

 

 

36,165

 

 

 

 

 

 

 

42,085

 

 

 

 

 

 

 


Sleep Number Announces Fourth-quarter and Full-year 2018 Results – Page 5 of 10

 

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Balance Sheets

(unaudited - in thousands, except per share amounts)

subject to reclassification

 

 

December 29, 2018

 

 

 

 

December 30, 2017

 

Assets

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

1,612

 

 

 

 

$

3,651

 

Accounts receivable, net of allowance for doubtful accounts of $699 and $714, respectively

 

 

24,795

 

 

 

 

 

19,312

 

Inventories

 

 

84,882

 

 

 

 

 

84,298

 

Prepaid expenses

 

 

8,009

 

 

 

 

 

17,565

 

Other current assets

 

 

31,559

 

 

 

 

 

27,665

 

Total current assets

 

 

150,857

 

 

 

 

 

152,491

 

 

 

 

 

 

 

 

 

 

 

 

Non-current assets:

 

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

205,631

 

 

 

 

 

208,646

 

Goodwill and intangible assets, net

 

 

75,407

 

 

 

 

 

77,588

 

Deferred income taxes

 

 

 

 

 

 

 

2,625

 

Other non-current assets

 

 

38,243

 

 

 

 

 

30,484

 

Total assets

 

$

470,138

 

 

 

 

$

471,834

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities and Shareholders’ (Deficit) Equity

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

Borrowings under revolving credit facility

 

$

199,600

 

 

 

 

$

24,500

 

Accounts payable

 

 

144,781

 

 

 

 

 

129,194

 

Customer prepayments

 

 

27,066

 

 

 

 

 

27,767

 

Accrued sales returns

 

 

19,907

 

 

 

 

 

19,270

 

Compensation and benefits

 

 

27,700

 

 

 

 

 

34,602

 

Taxes and withholding

 

 

18,380

 

 

 

 

 

24,234

 

Other current liabilities

 

 

51,234

 

 

 

 

 

46,822

 

Total current liabilities

 

 

488,668

 

 

 

 

 

306,389

 

 

 

 

 

 

 

 

 

 

 

 

Non-current liabilities:

 

 

 

 

 

 

 

 

 

 

Deferred income taxes

 

 

4,822

 

 

 

 

 

 

Other non-current liabilities

 

 

86,198

 

 

 

 

 

76,289

 

Total non-current liabilities

 

 

91,020

 

 

 

 

 

76,289

 

Total liabilities

 

 

579,688

 

 

 

 

 

382,678

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ (deficit) equity:

 

 

 

 

 

 

 

 

 

 

Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding

 

 

 

 

 

 

 

 

Common stock, $0.01 par value; 142,500 shares authorized, 30,868 and 38,813 shares issued and outstanding, respectively

 

 

309

 

 

 

 

 

388

 

Additional paid-in capital

 

 

 

 

 

 

 

 

(Accumulated deficit) retained earnings

 

 

(109,859

)

 

 

 

 

88,768

 

Total shareholders’ (deficit) equity

 

 

(109,550

)

 

 

 

 

89,156

 

Total liabilities and shareholders’ (deficit) equity

 

$

470,138

 

 

 

 

$

471,834

 

 


Sleep Number Announces Fourth-quarter and Full-year 2018 Results – Page 6 of 10

 

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(unaudited – in thousands)

subject to reclassification

 

 

 

Twelve Months Ended

 

 

 

December 29, 2018

 

 

December 30, 2017

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net income

 

$

69,539

 

 

$

65,077

 

Adjustments to reconcile net income to net cash provided by

   operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

61,966

 

 

 

61,291

 

Stock-based compensation

 

 

11,412

 

 

 

15,763

 

Net (gain) loss on disposals and impairments of assets

 

 

(51

)

 

 

249

 

Deferred income taxes

 

 

7,447

 

 

 

2,042

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(5,483

)

 

 

393

 

Inventories

 

 

(584

)

 

 

(9,272

)

Income taxes

 

 

(6,561

)

 

 

1,697

 

Prepaid expenses and other assets

 

 

5,551

 

 

 

(12,405

)

Accounts payable

 

 

(9,894

)

 

 

21,779

 

Customer prepayments

 

 

(701

)

 

 

1,560

 

Accrued compensation and benefits

 

 

(6,872

)

 

 

15,398

 

Other taxes and withholding

 

 

707

 

 

 

(893

)

Other accruals and liabilities

 

 

5,064

 

 

 

9,928

 

Net cash provided by operating activities

 

 

131,540

 

 

 

172,607

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Purchases of property and equipment

 

 

(45,515

)

 

 

(59,829

)

Proceeds from sales of property and equipment

 

 

272

 

 

 

36

 

Net cash used in investing activities

 

 

(45,243

)

 

 

(59,793

)

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Net increase in short-term borrowings

 

 

182,336

 

 

 

28,094

 

Repurchases of common stock

 

 

(272,446

)

 

 

(155,245

)

Proceeds from issuance of common stock

 

 

2,788

 

 

 

3,241

 

Debt issuance costs

 

 

(1,014

)

 

 

(12

)

Net cash used in financing activities

 

 

(88,336

)

 

 

(123,922

)

 

 

 

 

 

 

 

 

 

Net decrease in cash, cash equivalents and restricted cash

 

 

(2,039

)

 

 

(11,108

)

Cash, cash equivalents and restricted cash, at beginning of period

 

 

3,651

 

 

 

14,759

 

Cash, cash equivalents and restricted cash, at end of period

 

$

1,612

 

 

$

3,651

 

 

Note - Effective December 31, 2017, we adopted the provisions of Accounting Standards Update No. 2016-18, Restricted Cash, on a retrospective basis. Amounts for prior periods have been retrospectively adjusted to conform to the current period presentation.

 

 


Sleep Number Announces Fourth-quarter and Full-year 2018 Results – Page 7 of 10

 

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Supplemental Financial Information

(unaudited)

 

 

 

Three Months Ended

 

 

Twelve Months Ended

 

 

 

December 29, 2018

 

 

December 30, 2017

 

 

December 29, 2018

 

 

December 30, 2017

 

Percent of sales:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Retail

 

 

91.1

%

 

 

91.7

%

 

 

91.5

%

 

 

91.7

%

Online and phone

 

 

8.3

%

 

 

7.7

%

 

 

7.6

%

 

 

7.0

%

Wholesale/other

 

 

0.6

%

 

 

0.6

%

 

 

0.9

%

 

 

1.3

%

Total

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales change rates:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Retail comparable-store sales

 

 

9

%

 

 

12

%

 

 

3

%

 

 

3

%

Online and phone

 

 

23

%

 

 

13

%

 

 

15

%

 

 

16

%

Company-Controlled comparable sales change

 

 

10

%

 

 

12

%

 

 

3

%

 

 

4

%

Net opened/closed stores

 

 

3

%

 

 

4

%

 

 

3

%

 

 

7

%

Total Company-Controlled Channel

 

 

13

%

 

 

16

%

 

 

6

%

 

 

11

%

Wholesale/other

 

 

11

%

 

 

(35

%)

 

 

(26

%)

 

 

(38

%)

Total

 

 

13

%

 

 

16

%

 

 

6

%

 

 

10

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stores open:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Beginning of period

 

 

569

 

 

 

553

 

 

 

556

 

 

 

540

 

Opened

 

 

20

 

 

 

6

 

 

 

53

 

 

 

36

 

Closed

 

 

(10

)

 

 

(3

)

 

 

(30

)

 

 

(20

)

End of period

 

 

579

 

 

 

556

 

 

 

579

 

 

 

556

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other metrics:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average sales per store ($ in 000's) 1

 

$

2,707

 

 

$

2,618

 

 

 

 

 

 

 

 

 

Average sales per square foot 1

 

$

998

 

 

$

995

 

 

 

 

 

 

 

 

 

Stores > $1 million net sales 2

 

 

98

%

 

 

98

%

 

 

 

 

 

 

 

 

Stores > $2 million net sales 2

 

 

65

%

 

 

61

%

 

 

 

 

 

 

 

 

Average revenue per mattress unit 3

 

$

4,623

 

 

$

4,421

 

 

$

4,482

 

 

$

4,283

 

 

1 Trailing twelve months Company-Controlled comparable sales per store open at least one year.

2 Trailing twelve months for stores open at least one year.

3 Represents Company-Controlled Channel total net sales divided by Company-Controlled Channel mattress units.

 

 

 


Sleep Number Announces Fourth-quarter and Full-year 2018 Results – Page 8 of 10

 

SLEEP NUMBER CORPORATION AND SUBSIDIARIES

Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)

(in thousands)

 

We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure:

 

 

 

Three Months Ended

 

 

Trailing-Twelve Months Ended

 

 

 

December 29, 2018

 

 

December 30, 2017

 

 

December 29, 2018

 

 

December 30, 2017

 

Net income

 

$

26,990

 

 

$

15,791

 

 

$

69,539

 

 

$

65,077

 

Income tax expense

 

 

9,037

 

 

 

4,119

 

 

 

16,982

 

 

 

25,961

 

Interest expense

 

 

2,094

 

 

 

227

 

 

 

5,911

 

 

 

975

 

Depreciation and amortization

 

 

15,227

 

 

 

15,237

 

 

 

61,648

 

 

 

61,077

 

Stock-based compensation

 

 

1,314

 

 

 

3,954

 

 

 

11,412

 

 

 

15,763

 

Asset impairments

 

 

(19

)

 

 

20

 

 

 

96

 

 

 

244

 

Adjusted EBITDA

 

$

54,643

 

 

$

39,348

 

 

$

165,588

 

 

$

169,097

 

 

Free Cash Flow

(in thousands)

 

 

 

Three Months Ended

 

 

Trailing-Twelve Months Ended

 

 

 

December 29, 2018

 

 

December 30, 2017

 

 

December 29, 2018

 

 

December 30, 2017

 

Net cash (used in) provided by

   operating activities

 

$

(2,910

)

 

$

(3,447

)

 

$

131,540

 

 

$

172,607

 

Subtract: Purchases of property and

   equipment

 

 

11,503

 

 

 

22,216

 

 

 

45,515

 

 

 

59,829

 

Free cash flow

 

$

(14,413

)

 

$

(25,663

)

 

$

86,025

 

 

$

112,778

 

 

 

Note - Our Adjusted EBITDA calculation and our "free cash flow" data are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

 

GAAP - generally accepted accounting principles in the U.S.

 

 


Sleep Number Announces Fourth-quarter and Full-year 2018 Results – Page 9 of 10

 

SLEEP NUMBER CORPORATION AND SUBSIDIARIES

Calculation of Return on Invested Capital (ROIC)

(in thousands)

 

ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our invested capital. Management believes ROIC is also a useful metric for investors and financial analysts. We compute ROIC as outlined below. Our definition and calculation of ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile net operating profit after taxes (NOPAT) and total invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:

 

 

Trailing-Twelve Months Ended

 

 

 

December 29, 2018

 

 

December 30, 2017

 

Net operating profit after taxes (NOPAT)

 

 

 

 

 

 

 

 

Operating income

 

$

92,428

 

 

$

91,915

 

Add: Rent expense 1

 

 

79,390

 

 

 

74,019

 

Add: Interest income

 

 

4

 

 

 

97

 

Less: Depreciation on capitalized operating leases 2

 

 

(20,392

)

 

 

(18,865

)

Less: Income taxes 3

 

 

(36,444

)

 

 

(48,970

)

NOPAT

 

$

114,986

 

 

$

98,196

 

 

 

 

 

 

 

 

 

 

Average invested capital

 

 

 

 

 

 

 

 

Total (deficit) equity

 

$

(109,550

)

 

$

89,156

 

Add: Long-term debt 4

 

 

200,458

 

 

 

 

Add: Capitalized operating lease obligations 5

 

 

635,120

 

 

 

592,152

 

Total invested capital at end of period

 

$

726,028

 

 

$

681,308

 

 

 

 

 

 

 

 

 

 

Average invested capital 6

 

$

719,055

 

 

$

686,436

 

 

 

 

 

 

 

 

 

 

Return on invested capital (ROIC) 7

 

 

16.0

%

 

 

14.3

%

 

1

Rent expense is added back to operating income to show the impact of owning versus leasing the related assets.

2

Depreciation is based on the average of the last five fiscal quarters' ending capitalized operating lease obligations (see note 6) for the respective reporting periods with an assumed thirty-year useful life. This is subtracted from operating income to illustrate the impact of owning versus leasing the related assets.

3

Reflects annual effective income tax rates, before discrete adjustments, of 24.1% and 33.3% for 2018 and 2017, respectively.

4

Long-term debt includes existing capital lease obligations, if applicable. In conjunction with increasing our revolving credit facility to $300 million in the first quarter of 2018, we include borrowing under that agreement, including borrowings classified as short term.

5

A multiple of eight times annual rent expense is used as an estimate for capitalizing our operating lease obligations. The methodology utilized aligns with the methodology of a nationally recognized credit rating agency.

6

Average invested capital represents the average of the last five fiscal quarters' ending invested capital balances.

7

ROIC equals NOPAT divided by average invested capital.

 

Note - Our ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

 

GAAP - generally accepted accounting principles in the U.S.

 


Sleep Number Announces Fourth-quarter and Full-year 2018 Results – Page 10 of 10

 

SLEEP NUMBER CORPORATION AND SUBSIDIARIES

Reconciliation of Non-GAAP Financial Measures

(unaudited - in million, except per share amounts)

 

Net sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1st Quarter

 

 

2nd Quarter

 

 

3rd Quarter

 

 

4th Quarter

 

 

Full-Year

 

 

First Half

 

 

Second Half

 

2018

As Reported

 

$

389

 

 

$

316

 

 

$

415

 

 

$

412

 

 

$

1,532

 

 

$

705

 

 

$

827

 

 

Backlog shift1

 

 

 

 

 

 

 

 

24

 

 

 

(24

)

 

 

 

 

 

 

 

 

 

 

As-Adjusted

 

$

389

 

 

$

316

 

 

$

439

 

 

$

388

 

 

$

1,532

 

 

$

705

 

 

$

827

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1st Quarter

 

 

2nd Quarter

 

 

3rd Quarter

 

 

4th Quarter

 

 

Full-Year

 

 

First Half

 

 

Second Half

 

2017

As Reported

 

$

394

 

 

$

285

 

 

$

403

 

 

$

363

 

 

$

1,444

 

 

$

679

 

 

$

766

 

 

Backlog shift2

 

 

 

 

 

25

 

 

 

(25

)

 

 

 

 

 

 

 

 

25

 

 

 

(25

)

 

Hurricane impact3

 

 

 

 

 

 

 

 

13.5

 

 

 

(13.5

)

 

 

 

 

 

 

 

 

 

 

As-Adjusted

 

$

394

 

 

$

310

 

 

$

391

 

 

$

350

 

 

$

1,444

 

 

$

704

 

 

$

741

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per diluted share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1st Quarter

 

 

2nd Quarter

 

 

3rd Quarter

 

 

4th Quarter

 

 

Full-Year

 

 

First Half

 

 

Second Half

 

2018

As Reported

 

$

0.52

 

 

$

0.10

 

 

$

0.52

 

 

$

0.81

 

 

$

1.92

 

 

$

0.64

 

 

$

1.32

 

 

Backlog shift1,4

 

 

 

 

 

 

 

 

0.23

 

 

 

(0.23

)

 

 

 

 

 

 

 

 

 

 

As-Adjusted

 

$

0.52

 

 

$

0.10

 

 

$

0.75

 

 

$

0.58

 

 

$

1.92

 

 

$

0.64

 

 

$

1.32

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1st Quarter

 

 

2nd Quarter

 

 

3rd Quarter

 

 

4th Quarter

 

 

Full-Year

 

 

First Half

 

 

Second Half

 

2017

As Reported

 

$

0.56

 

 

$

(0.02

)

 

$

0.62

 

 

$

0.39

 

 

$

1.55

 

 

$

0.55

 

 

$

1.01

 

 

Backlog shift2,5

 

 

 

 

 

0.12

 

 

 

(0.12

)

 

 

 

 

 

 

 

 

0.12

 

 

 

(0.12

)

 

Hurricane impact3,5

 

 

 

 

 

 

 

 

0.06

 

 

 

(0.06

)

 

 

 

 

 

 

 

 

 

 

As-Adjusted

 

$

0.56

 

 

$

0.10

 

 

$

0.56

 

 

$

0.33

 

 

$

1.55

 

 

$

0.67

 

 

$

0.89

 

 

1

Midpoint of estimated net sales and earnings per share impact (21 to 25 cents) related to strong demand late in the quarter which shifted a week of deliveries from the third to fourth quarter of 2018; third-quarter 2018 ending order backlog was higher than forecasted, reflecting the additional week of deliveries shifted to the fourth quarter

2

Estimated net sales and earnings per share impact related to a temporary vendor related inventory shortage which shifted a week of deliveries from the second to third quarter of 2017

3

Midpoint of estimated net sales ($12 to $15 million) and earnings per share impact (5 to 8 cents) of Hurricanes Harvey and Irma, which negatively impacted third-quarter 2017 results and positively impacted fourth-quarter 2017 results as lost sales were recovered

4

Reflects annual effective income tax rate, before discrete adjustments, of 24.1% for 2018

5

Reflects annual effective income tax rate, before discrete adjustments, of 33.3% for 2017

  

Note: The information above provides reconciliations of the comparable financial measures in accordance with generally accepted accounting principles (GAAP financial measures) to the presented non-GAAP financial measures. The company believes that non-GAAP financial measures, when reviewed in conjunction with GAAP financial measures, can provide more information to assist investors and management in evaluating current period performance and in assessing future performance. The estimates above are based on historical experience, current trends and other factors that management believes to be relevant, and as such requires the use of judgment. These non-GAAP financial measures should be considered in addition to, and not preferable to or as a substitute for, the GAAP financial measures presented in this earnings release and the company’s financial statements and other publicly filed reports. Non-GAAP measures as presented herein may not be comparable to similarly titled measures used by other companies.